## Abstract Huntington's disease is a neurodegenerative condition, characterized by movement disorders, cognitive decline, and psychiatric disturbance. We review the pharmacological management of the various movement disorders associated with the disease, the cognitive decline and the commonly enco
β¦ LIBER β¦
the management of Huntington's disease
- Book ID
- 111196008
- Publisher
- BMJ Publishing Group
- Year
- 2004
- Tongue
- English
- Weight
- 179 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1474-7758
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The current clinical management of Hunti
β
Wendy Phillips; Kathleen M. Shannon; Roger A. Barker
π
Article
π
2008
π
John Wiley and Sons
π
English
β 225 KB
Efficient repetitive alteration of the m
β
Jamie A. Cearley; Peter J. Detloff
π
Article
π
2001
π
Springer Netherlands
π
English
β 138 KB
Huntington's disease: GP guide to clinic
β
George El-Nimr; Ken Barrett
π
Article
π
2006
π
Wiley (John Wiley & Sons)
π
English
β 150 KB
Huntington's disease
β
David Craufurd
π
Article
π
1996
π
John Wiley and Sons
π
English
β 873 KB
Huntington's disease (HD) is a late-onset degenerative disorder of the central nervous system, caused by a dominantly inherited mutation in a gene on chromosome 4p. The identification of the trinucleotide repeat mutation responsible for this disorder has been an important step towards understanding
Huntingtonβs Disease
β
Marcy E. MacDonald; Silvia Gines; James F. Gusella; Vanessa C. Wheeler
π
Article
π
2003
π
Humana Press Inc
π
English
β 267 KB
Huntington's Disease
β
Clay Farris Naff
π
Fiction
π
2012
π
Greenhaven Publishing, LLC
π
en-US
β 4 MB
Huntington's Disease causes degeneration of brain cells, in motor control regions of the brain, as well as other areas. Symptoms get progressively worse, and include uncontrolled movements, abnormal body postures, and changes in emotion, behavior, judgment, and cognition. People with HD also develop